An interventional study of PAT+HEALTH curriculum - Nigeria in Hypertension in Pregnancy, Hypertension and Obesity and Overweight, sponsored by Washington University School of Medicine. Active, not recruiting at 1 site in Nigeria. Open to female participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-07-24.
Sponsored by Washington University School of Medicine · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
The purpose of the ENHANCE-CVH study is to promote intergenerational cardiovascular health (CVH) of women and children in Abuja and the surrounding Federal Capital Territory of Nigeria. The study team plans to achieve this through an adaptation of an existing evidence based intervention - Parents as Teachers (PAT) curriculum + Healthy Eating Active Living Taught at Home (HEALTH) - among pregnant women with obesity and their children in Nigeria. The aim of the study is to evaluate the effectiveness and implementation of community health educator-led delivery of the PAT+HEALTH intervention via home visits to answer the following main questions:
Participants in the study will complete baseline surveys and have clinical data, lab data, and body measurements captured. Participants will also have these procedures repeated at birth and every 6 months up to 24 months post-delivery. Once randomized to the intervention group, participants will complete 40 biweekly PAT+HEALTH curriculum delivery sessions, each lasting approximately 60-90 minutes.
262 studies on the registry are indexed under Hypertension, Pregnancy-Induced; 70 are open to participants now.
This study's planned enrollment of 1,000 is above the median of 147 across 174 interventional studies indexed under Hypertension, Pregnancy-Induced.
Browse Hypertension, Pregnancy-Induced studies →Washington University School of Medicine is the lead sponsor of 1,806 studies on the registry; 271 are open to participants now.
Of its 329 completed or terminated interventional studies of FDA-regulated products, 216 (66%) have results posted.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
•≥18 years of age,
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.
What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Anti-inflammatory medicines such as prednisone, prednisolone and dexamethasone — not the anabolic steroids used for muscle.
Studies differ in what they allow: check which steroid medicines, routes (tablets, injections, creams, inhalers, eye drops) and doses this study accepts.
BMI (body mass index)
Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.
What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Corticosteroids (steroids)
Anti-inflammatory medicines such as prednisone, prednisolone and dexamethasone — not the anabolic steroids used for muscle.
Studies differ in what they allow: check which steroid medicines, routes (tablets, injections, creams, inhalers, eye drops) and doses this study accepts.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Participants randomized to this arm will receive 40 biweekly PAT+HEALTH intervention delivery ante- and postnatally. These will primarily focus on promoting cardiovascular health for mother and child through lifestyle and behavioral modifications along with additional support and education for pregnancy and cardiovascular health.
Behavioral: PAT+HEALTH curriculum - Nigeria
Participants randomized to the control group will not receive the PAT+HEALTH intervention and will only receive standard ante- and postnatal care.
This intervention is an adaption of the PAT Curriculum and the HEALTH intervention specifically tailored for the Nigerian context.
Change in maternal body weight from baseline
Between group difference in change in maternal body weight f rom baseline to 18-month follow-up measured in kilograms.
Time frame: Baseline to 18-month postnatal follow up
Change in cardiovascular health score
Between group difference in change in maternal cardiovascular health score (range from 0-100: Life's Essential 8) from baseline to 18-month postnatal follow-up.
Time frame: Baseline to 18-month postnatal follow up
Change in cardiovascular health score - Tobacco Use/Exposure
Between group difference in change in Tobacco Use/exposure subscore (range from 0-100: Life's Essential 8) from baseline to 18-month postnatal follow-up.
Time frame: Baseline to 18-month postnatal follow up
Change in cardiovascular health score - Diet
Between group difference in change in Diet subscore (range from 0-100: Life's Essential 8) from baseline to 18-month postnatal follow-up.
Time frame: Baseline to 18-month postnatal follow up
Change in cardiovascular health score - Physical Activity
Between group difference in change in Physical Activity subscore (range from 0-100: Life's Essential 8) from baseline to 18-month postnatal follow-up.
Time frame: Baseline to 18-month postnatal follow up
Change in cardiovascular health score - BMI
Between group difference in change in BMI subscore (range from 0-100: Life's Essential 8) from baseline to 18-month postnatal follow-up.
Time frame: Baseline to 18-month postnatal follow up
Change in cardiovascular health score - Blood Pressure
Between group difference in change in blood pressure subscore (range from 0-100: Life's Essential 8) from baseline to 18-month postnatal follow-up.
Time frame: Baseline to 18-month postnatal follow up
Change in cardiovascular health score - Cholesterol
Between group difference in change in cholesterol subscore (range from 0-100: Life's Essential 8) from baseline to 18-month postnatal follow-up.
Time frame: Baseline to 18-month postnatal follow up
Change in cardiovascular health score - Blood Sugar
Between group difference in change in Blood Sugar subscore (range from 0-100: Life's Essential 8) from baseline to 18-month postnatal follow-up.
Time frame: Baseline to 18-month postnatal follow up
Change in cardiovascular health score - Sleep
Between group difference in change in Sleep subscore (range from 0-100: Life's Essential 8) from baseline to 18-month postnatal follow-up.
Time frame: Baseline to 18-month postnatal follow up
Change in Child CVH behaviors - Diet
Between group difference in child cardiovascular health behaviors as measured through parent-reported diet from birth to 18 months.
Time frame: Birth to 18 months
Change in Child CVH behaviors - Physical Activity
Between group difference in child cardiovascular health behaviors as measured through parent-reported activity from birth to 18 months using the Movement Behavior Questionnaire - Child Open Version (MBQ-C)
Time frame: Birth to 18 months
Change in Child CVH behaviors - Sleep
Between group difference in child cardiovascular health behaviors as measured through parent-reported sleep from birth to 18 months using the Brief Infant Sleep Questionnaire - Revised version (BISQ-R)
Time frame: Birth to 18 months
Maternal Mortality
Between group difference in composite rate of maternal mortality from baseline to 18 months postnatal follow-up
Time frame: Baseline to 18-month postnatal follow up
Maternal morbidity
Between group difference in composite rate of maternal morbidity (defined as occurrence of any serious adverse event) from baseline to 18 month postnatal follow-up.
Time frame: Baseline to 18-month postnatal follow up
Stillbirth or spontaneous abortion
Between group difference in the composite rate of stillbirth or spontaneous abortion.
Time frame: Measured at Birth
Neonatal, infant, and child mortality
Between group difference in the composite rate of neonatal, infant, or childhood mortality from birth to 18 months.
Time frame: Birth to 18 months
Neonatal, infant, and child morbidity
Between group difference in the composite rate of neonatal, infant, or childhood morbidity as defined by occurrence of any serious adverse events from birth to 18 months.
Time frame: Birth to 18 months
Child Weight for length
Between group difference in child weight-for-length z-score at 6 and 18 months, adjusted for weight-for-length z-score at birth.
Time frame: Birth, 6 months, 18 months
Child BMI
Between group difference in child BMI z-score at 6 and 18 months, adjusted for weight-for-length z-score at birth.
Time frame: Birth, 6 months, 18 months
Parental feeding behaviors
Parental feeding behaviors measured by the Feeding to Manage Child Behavior Questionnaire (FMCBQ)
Time frame: 6 months, 12 months, 18 months, 24 months
Plan to share: Yes — De-identified data will be made available after the conclusion of the study following the guidelines of BioData Catalyst. A codebook will be provided.
Supporting information: Study protocol, Informed consent form
Time frame: Beginning not later than 6 months after publication of results with no end date.
Access criteria: Those who have privileges to access data stored within the BioData Catalyst repository may access the data as per the rules and regulations of that system. Data provided to BioData Catalyst will be completely de-identified following their criteria.
Started Jun 2025 (actual). Primary completion is estimated for Oct 2027, 28 months after the start.
Of 91 non-industry interventional studies with no phase under Hypertension, Pregnancy-Induced, half reached primary completion within 24 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 34. This study's planned 28 months is above that.
Counting every sponsor, half of 92 studies reached it within 24 months; a quarter within 10 and three quarters within 34.
How these figures are worked out, and which studies are left out of them.
This study is active, not recruiting, as verified in Jul 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Hypertension, Pregnancy-Induced →
Washington University School of Medicine →